Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mediated reactions
- PMID: 2419443
Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mediated reactions
Abstract
We have shown that fluids collected from antigen-challenged skin blisters during the late phase reaction cause the release of substantial amounts of histamine (means = 42%, n = 14) from human basophils in vitro. Control fluids collected either during the immediate phase or from an unchallenged blister released less than or equal to 10% histamine from both basophils and lung mast cells. Late phase blister fluids induced low levels of histamine release from human lung cells (means = 11%, n = 4) that were slightly but not significantly greater than levels induced by control blister fluids. The characteristics of basophil release were similar to IgE-mediated stimuli in dose dependence, calcium and temperature requirements, and kinetics. The IgE dependence of the late phase blister fluid was demonstrated by desensitization of the basophils to anti-IgE, which obviated the response to anti-IgE and blister fluid but did not affect a non-IgE-mediated stimulus. Removal of the cell surface IgE with lactic acid also abolished the response to both anti-IgE and late phase blister fluid. Incubation of the "stripped" cells with serum containing IgE myeloma restored the response to anti-IgE but failed to affect response to late phase blister fluid. The characteristics of release obtained with this factor closely resemble those of an IgE-dependent histamine releasing factor from cultured macrophages previously described by our group.
Similar articles
-
Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors.J Immunol. 1986 Apr 1;136(7):2588-95. J Immunol. 1986. PMID: 2419444
-
Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE.J Immunol. 1987 Jul 15;139(2):506-12. J Immunol. 1987. PMID: 2439589
-
Recombinant IL-3 induces histamine release from human basophils.J Immunol. 1989 May 15;142(10):3527-32. J Immunol. 1989. PMID: 2469718
-
Basophil-mast cell response syndromes: a unified clinical approach.Allergy Proc. 1988 Nov-Dec;9(6):611-20. doi: 10.2500/108854188778965410. Allergy Proc. 1988. PMID: 3066689 Review.
-
Histamine-releasing factors and inhibitors: historical perspectives and possible implications in human illness.J Allergy Clin Immunol. 1991 Nov;88(5):683-93. doi: 10.1016/0091-6749(91)90170-s. J Allergy Clin Immunol. 1991. PMID: 1720148 Review.
Cited by
-
Dimerization of translationally controlled tumor protein is essential for its cytokine-like activity.PLoS One. 2009 Jul 31;4(7):e6464. doi: 10.1371/journal.pone.0006464. PLoS One. 2009. PMID: 19649253 Free PMC article.
-
An immunoglobulin E-dependent recombinant histamine-releasing factor induces interleukin-4 secretion from human basophils.J Exp Med. 1996 Mar 1;183(3):1265-70. doi: 10.1084/jem.183.3.1265. J Exp Med. 1996. PMID: 8642270 Free PMC article.
-
Histamine-releasing factor enhances food allergy.J Clin Invest. 2017 Dec 1;127(12):4541-4553. doi: 10.1172/JCI96525. Epub 2017 Nov 13. J Clin Invest. 2017. PMID: 29130935 Free PMC article. Clinical Trial.
-
Histamine-releasing factor and immunoglobulins in asthma and allergy.Allergy Asthma Immunol Res. 2014 Jan;6(1):6-12. doi: 10.4168/aair.2014.6.1.6. Epub 2013 Jul 2. Allergy Asthma Immunol Res. 2014. PMID: 24404387 Free PMC article. Review.
-
Th2 cytokines, IgE and mast cells play a crucial role in the induction of para-phenylenediamine-induced contact hypersensitivity in mice.Clin Exp Immunol. 2003 Jun;132(3):385-92. doi: 10.1046/j.1365-2249.2003.02164.x. Clin Exp Immunol. 2003. PMID: 12780683 Free PMC article.